Valrubicin

Valrubicin (AD 32) inhibits TPA- and PDBu-induced PKC activation (IC50s: 0.85 and 1.25 μM) and has antitumor and anti-inflammatory activity.

56124-62-0

≥ 2 years

>98% (HPLC)

723.64

C34H32F3NO13

Research use only, not for human use.

PKC

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-97813JF549 0.1 mL

Ask

MF-0091646-01 50 µL

Ask

MF-0091646-02 100 µL

Ask

MF-0091646-03 200 µL

Ask

MBS8213914-01 15 nmol

Ask

MBS8213914-02 30 nmol

Ask